Biotechnology & Medical Research
Foamix Pharmaceuticals Ltd : Foamix reports year end 2016 financial results and provides business update .Foamix Pharmaceuticals - estimates existing cash, investments provide sufficient financial flexibility to finance clinical, business operations into 2019.
Esperion Therapeutics Inc : Esperion provides bempedoic acid development program update; reports fourth quarter and full year 2016 financial results . Esperion Therapeutics Inc - expects full-year 2017 net cash used in operating activities to be approximately $125 to $135 million . Esperion...
Spark Therapeutics Inc :Spark Therapeutics reports 2016 financial results and business highlights.
Zhongyuan Union Cell & Gene Engineering Corp Ltd :Says it plans to acquire an investment management firm which owns genetic research firm OriGene Technologies Inc in the U.S..
No related earnings announcements are currently scheduled within the next 7 days.